Skip to main content
Equibles

Eric J. Daniels

Cerenome, Inc. (CNSY)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Eric J. Daniels

Cerenome, Inc. reported in an 8-K filed April 9, 2026 that Eric J. Daniels was appointed Chief Development Officer, effective April 20, 2026.

“On April 9, 2026, Plus Therapeutics, Inc. (the “Company”) announced the appointment of Dr. Eric J. Daniels as Chief Development Officer of the Company, effective April 20, 2026.”
Cerenome, Inc. Form 8-K, filed April 9, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Cerenome, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.